cd38 inhibitor and 5-amino-1mq synergy nad+ is a key mediator of depletion in the brain of ZIKV-infected mice: iScience CD38 as theranostic target in
CD38 as theranostic target in oncology Journal of Translational Medicine Springer Nature Link The CD38 glycohydrolase and the NAD sink: implications for pathological conditions American Journal of Physiology Cell Physiology American Physiological Society CD38 Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+ Lowering Agents Emerging chemical strategies for CD38 inhibition: restoring NAD+ metabolism and disease control ScienceDirect The Pharmacology of CD38 NADase: An emerging target for cancer and aging diseases PMC
Pay in 4 interest-free payments of $6.38 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




